None listed
Conditions
Interventions
Intervention1: EMERALD Module: The EMERALD (Multidimensional Effects, Risks, Awareness, and Lifestyle Decisions) module offers an
innovative approach by combining oral health education with strategies
Sponsors
DrVaibhav Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Gender & Age: a. Male individuals aged between 18 to 40 years. 2. AAS Use History: a. Self-reported current or past AAS use for at least three months. b. recreational and non-competitive AAS users. 3. Gym/Fitness Center Membership: a. Must be an active member of at least one gym or fitness center in Mumbai, categorized into three groups: i. Elite (high-end gyms with professional trainers and supplements access) ii. Mid-range (standard commercial gyms with moderate fees and accessibility) iii. Budget (affordable neighborhood gyms with minimal regulation and supervision) 4. Language Proficiency: a. Must be fluent in English, Hindi, or Marathi to ensure effective comprehension and engagement in the intervention. 5. Willingness to Participate: a. Must provide written informed consent to participate in the study. b. Willingness to attend all intervention sessions and complete the follow-up assessments
Exclusion criteria
Exclusion criteria: 1. Professional Athletes or Bodybuilders: a. Those currently competing in national or international sports/bodybuilding competitions where AAS use might be regulated or part of performance protocols. 2. Active Psychiatric Illness or Treatment: a. Individuals receiving ongoing psychiatric treatment for severe conditions such as schizophrenia, bipolar disorder, or major depressive disorder. b. Those with current or past history of psychosis attributed to AAS use. 3. Concurrent Substance Abuse: a. Individuals who report heavy or chronic use of other substances such as opioids, cocaine, or amphetamines. 4. Medical Conditions Contraindicating Participation: a. Those with severe cardiovascular disease, liver failure, or other serious systemic illnesses that might confound AAS-related health risks. 5. Unwillingness or Inability to Follow Study Protocol: a. Those unable to commit to attending intervention sessions or completing the follow-up assessments. 7 b. Those unwilling to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The EMERALD module demonstrated significant short-term effectiveness in improving awareness, altering risk perception, and encouraging healthier decision-making among AAS users in Mumbai. By integrating oral health into a holistic harm reduction framework using interactive, evidence-based methods, the study addressed a major gap in current interventions. Results support EMERALD as a replicable, scalable model for future public health programs targeting performance-enhancing substance misuse.Timepoint: The study will begin with EMERALD module development and validation (Weeks 1 4), followed by recruitment of male AAS users (Weeks 5 6). Baseline assessment will be conducted (Week 7), then educational sessions delivered (Weeks 8 9). Post-test evaluation will take place (Week 10), with a follow-up after 21 days (Week 13). Data will be analyzed (Weeks 14 16), and the final report will be submitted (Weeks 17 18). | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Vaibhav Kumar
Dr. G. D. Pol Foundation, Y. M. T. Dental college and hospital
Outcome results
None listed